T. P. Rahmani, Y. Harahap, and D. J. Purwanto, “A review of the relationship between Doxorubicin and Doxorubicinol, CBR1 polymorphism, and cardiotoxicity”, Pharm Educ, vol. 24, no. 6, pp. p. 105–115, Jun. 2024.